ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

By Gareth Macdonald

- Last updated on GMT

The Big Pharma CRO strategic partnering model, its impact on drug development and the contract research sector was a hot topic at DIA 2011.

Outsourcing-pharma.com asked representatives from Quintiles Transnational, PRA International and Theorem Clinical Research to share their thoughts on such deals and whether they are good for the sector as a whole.

We also spoke with John Lewis, Vice President of Public Affairs at the Association of Clinical Research Organizations (ACRO) who suggested that more research is needed to assess the efficacy of strategic partnerships.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars